A Study of Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy
Clinical trial NCT03830411 · UNKNOWN
Trial details
- NCT number
- NCT03830411
- Sponsor
- Xin-Hua Xu
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-13
- Primary completion
- 2022-06-30
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.